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Fig. 3.
Conclusion: Our ﬁndings indicate that a deletion of Bim/Bid can reduce
but not prevent chondrocyte apoptosis in response to mechanical injury.
Our results are consistent with previous ﬁnding where a nitric oxide
scavenger was able to reduce the incidence of chondrocyte apoptosis
after traumatic injury. Since Bim (mitochondrial intrinsic) pathway has
been shown to play a role in mediating nitric oxide induced apoptosis
it is assumed that the Bim deletion also works through this mechanism.
Additional studies are ongoing to determine whether these ﬁndings are
due to a delay in the occurrence of apoptosis or long-term (>48 hours)
prevention of chondrocyte apoptosis.
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Purpose: Periostin (POSTN), a gamma-carboxylated extracellular matrix
protein originally identiﬁed as an osteoblast stimulating factor. This study
investigates its expression in OA cartilage and regulation of chondrocyte
metabolism.
Methods: Cartilage slices were obtained from the advanced OA patients
(age 45–80 years) undergoing knee replacement surgery. Non-arthritic
knee cartilages were obtained from autopsy patients within 24h (NDRI,
Philadelphia). Predesigned TaqMan PCR primers were purchased from
Applied Biosystems. Lentiviral shRNA targeting POSTN were purchased
from Sigma. Matrix metalloproteinases proMMP-1 and proMMP-13 ELISA
kits were from R&D Systems. Degradation products of type II collagen
was measured using CTX II-based assay kit.
Results: We studied the expression of POSTN in pools (n = 10) of OA and
age-matched non-diseased cartilage using U133 Affymetrix microarray.
POSTN was overexpressed 2–4 fold in OA cartilage (p < 0.035) compared
to non-diseased controls. Veriﬁcation by real-time PCR conﬁrmed POSTN
upregulation. Surgical-induction of OA in rats by anterior cruciate
ligament transection (ACLT) and destabilization of the medial meniscus
(DMM) models also signiﬁcantly increased POSTN (3–11 fold) from
2–8 weeks after surgery. In OA chondrocytes isolated from human tibial
cartilage, POSTN mRNA levels, determined by qPCR, were inhibited 3-fold
in the presence of inﬂammatory cytokines IL-1b and TNFa. In contrast,
TGFb-1 (2 ng/ml) signiﬁcantly increased POSTN expression (2–40-fold). In
functional assays, exogenously added (1–30 ug/ml) or overexpression of
POSTN signiﬁcantly increased MMP-13 expression and activity (p < 0.02)
in primary human OA, rat and bovine chondrocytes. Conversely; knock
down of endogenous POSTN using targeted lentiviral shRNAs signiﬁcantly
decreased MMP-13 expression in the presence of TGF-b1. In OA cartilage
explants cultures, PSTN increased cartilage degeneration, evidenced by
increased release of collagen (C1, 2C) and GAG fragments in culture
supernatants. To determine whether PSTN is a hypertrophic marker
of chondrocytes we examined its expression in chondrogenesis assays
using human bone marrow-derived MSCs and immature murine costal
chondrocytes undergoing maturation. In both assays PSTN expression
was upregulated in a time-dependent manner, and expression coincided
with MMP-13, Alkaline Phosphatase and F-spondin. These ﬁndings
suggest that PSTN expression is associated with chondrocyte terminal
differentiation.
Conclusions: Together, these studies indicate that PSTN is a marker of
OA cartilage and chondrocyte hypertrophy. In OA, PSTN may contribute
to disease pathogenesis by promoting cartilage degradation via induction
of MMP-13.
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NATURAL HISTORY OF BONE AND CARTILAGE CHANGES IN
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Purpose: Emerging evidence indicates that 50–75% of variation in OA
is genetic, however, little evidence is available on the genes that cause
OA or protect from OA. It has been demonstrated that speciﬁc strains of
mice (MRL/MpJ and DBA/1) are protected from post-traumatic arthritis
in young animals and age-related OA in older animals.
In the present study, selected recombinant inbred (RI) lines of SM/J
mice and LG/J were used; strains 6 and 33. RI strains are genetically
identical but each strain is a different recombination of the parental
genotypes, so we can predict that their outcomes are due to different
composition of the genome. Strain 6 and 33 were chosen because they
represent extremes of healing ability in the RI population. Preliminary
data indicated that strain 6 could heal an ear hole punch while strain
33 could not. The aim of this study is to compare the strain-dependent
development of OA following DMM surgery, assessed by measurements
of cartilage and bone over time. We also correlated the development of
OA with ear tissue regeneration potential and ability to repair cartilage.
Methods: Selected RI strains (strain 6 and 33) were subjected to
destabilization of medial meniscus (DMM) at 10 weeks of age in
right knee joint by transection of the medial meniscotibial ligament.
Cartilage degeneration was evaluated with histological sections stained
with Toluidine blue and scored with scoring system at 2, 4, and
8 weeks after surgery (n =8 at each time point). Bone changes
were analyzed with micro-computed tomography (micro-CT) scanner
at the same time-points as histological evaluation. The following
morphometric parameters of the tibial subchondral plate were calculated
for subchondral bone thickness, and trabecular bone compartments:
trabecular bone volume fraction, trabecular thickness and trabecular
connective density.
Fig. 1. (A) histological OA score of strains 6 and 33. (B) Subchondral bone
thickness in medial tibial plateau of strains 6 and 33. (*p < 0.05).
Results: Histological sections showed more cartilage degeneration in
strain 33 than strain 6 mice after DMM surgery. For the summed OA
score, strain 33 mice developed OA in a time-dependent manner and
signiﬁcantly higher grade of OA than strain 6 mice after 4 and 8 weeks of
DMM surgery (Figure 1A). Strain 33 showed subchondral bone thinning
in early time points (2 and 4 weeks), however the subchondral bone
